Table 1. Drugs for Irritable Bowel Syndrome Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Drugs for Irritable Bowel Syndrome Market Restraints

Table 3. Drugs for Irritable Bowel Syndrome Market Trends

Table 4. Drugs for Irritable Bowel Syndrome Industry Policy

Table 5. Global Drugs for Irritable Bowel Syndrome Revenue by Company (2019-2023) & (US$ million)

Table 6. Global Drugs for Irritable Bowel Syndrome Revenue Market Share by Company (2019-2023)

Table 7. Global Drugs for Irritable Bowel Syndrome Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Drugs for Irritable Bowel Syndrome Mergers & Acquisitions, Expansion Plans

Table 9. Global Drugs for Irritable Bowel Syndrome Manufacturers Product Type

Table 10. China Drugs for Irritable Bowel Syndrome Revenue by Company (2019-2023) & (US$ million)

Table 11. China Drugs for Irritable Bowel Syndrome Revenue Market Share by Company (2019-2023)

Table 12. Global Key Players of Drugs for Irritable Bowel Syndrome Upstream (Raw Materials)

Table 13. Global Drugs for Irritable Bowel Syndrome Typical Customers

Table 14. Drugs for Irritable Bowel Syndrome Typical Distributors

Table 15. By Type, Global Drugs for Irritable Bowel Syndrome Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 16. By Application, Global Drugs for Irritable Bowel Syndrome Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 17. By Region, Global Drugs for Irritable Bowel Syndrome Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 18. By Region, Global Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Drugs for Irritable Bowel Syndrome Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 20. By Country, Global Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2030

Table 22. Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position

Table 23. Takeda Pharmaceutical Company Limited Company Profile and Main Business

Table 24. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 25. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 26. Takeda Pharmaceutical Company Limited Recent Developments

Table 27. Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

Table 28. Pfizer, Inc. Company Profile and Main Business

Table 29. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 30. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 31. Pfizer, Inc. Recent Developments

Table 32. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 33. Abbott Laboratories Company Profile and Main Business

Table 34. Abbott Laboratories Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 35. Abbott Laboratories Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 36. Abbott Laboratories Recent Developments

Table 37. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 38. Novartis AG Company Profile and Main Business

Table 39. Novartis AG Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 40. Novartis AG Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 41. Novartis AG Recent Developments

Table 42. AstraZeneca PLC Company Information, Head Office, Market Area and Industry Position

Table 43. AstraZeneca PLC Company Profile and Main Business

Table 44. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 45. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 46. AstraZeneca PLC Recent Developments

Table 47. Ironwood Pharmaceuticals Inc. and Allergan Plc Company Information, Head Office, Market Area and Industry Position

Table 48. Ironwood Pharmaceuticals Inc. and Allergan Plc Company Profile and Main Business

Table 49. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 50. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 51. Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Developments

Table 52. Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position

Table 53. Bausch Health Companies Inc. Company Profile and Main Business

Table 54. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 55. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 56. Bausch Health Companies Inc. Recent Developments

Table 57. GlaxoSmithKline, Plc. Company Information, Head Office, Market Area and Industry Position

Table 58. GlaxoSmithKline, Plc. Company Profile and Main Business

Table 59. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 60. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 61. GlaxoSmithKline, Plc. Recent Developments

Table 62. Lexicon Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

Table 63. Lexicon Pharmaceuticals, Inc. Company Profile and Main Business

Table 64. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 65. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 66. Lexicon Pharmaceuticals, Inc. Recent Developments

Table 67. Sucampo Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

Table 68. Sucampo Pharmaceuticals, Inc. Company Profile and Main Business

Table 69. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Models, Specifications and Application

Table 70. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue and Gross Margin, 2019-2023

Table 71. Sucampo Pharmaceuticals, Inc. Recent Developments

List of Figure

Figure 1. Drugs for Irritable Bowel Syndrome Picture

Figure 2. Global Drugs for Irritable Bowel Syndrome Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Drugs for Irritable Bowel Syndrome Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Drugs for Irritable Bowel Syndrome Market Share of Global

Figure 5. Global Drugs for Irritable Bowel Syndrome Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 6. Global Drugs for Irritable Bowel Syndrome Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2023

Figure 7. China Drugs for Irritable Bowel Syndrome Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 8. China Drugs for Irritable Bowel Syndrome Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 9. Drugs for Irritable Bowel Syndrome Industry Chain

Figure 10. Alosetron

Figure 11. Lubiprostone

Figure 12. Linaclotide

Figure 13. Others

Figure 14. By Type, Global Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, US$ Million

Figure 15. By Type, Global Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2030

Figure 16. Hospital

Figure 17. Clinic

Figure 18. Others

Figure 19. By Application, Global Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, US$ Million

Figure 20. By Application, Global Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2030

Figure 21. By Region, Global Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2030

Figure 22. North America Drugs for Irritable Bowel Syndrome Revenue & Forecasts, 2019-2030, US$ Million

Figure 23. By Country, North America Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2023

Figure 24. Europe Drugs for Irritable Bowel Syndrome Revenue & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, Europe Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2023

Figure 26. Asia Pacific Drugs for Irritable Bowel Syndrome Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country/Region, Asia Pacific Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2023

Figure 28. South America Drugs for Irritable Bowel Syndrome Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country, South America Drugs for Irritable Bowel Syndrome Revenue Market Share, 2019-2023

Figure 30. Middle East & Africa Drugs for Irritable Bowel Syndrome Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. U.S. Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 32. By Company, U.S. Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 33. By Type, U.S. Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 34. By Application, U.S. Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 35. Europe Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 36. By Company, Europe Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 37. By Type, Europe Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 38. By Application, Europe Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 39. China Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 40. By Company, China Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 41. By Type, China Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 42. By Application, China Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 43. Japan Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 44. By Company, Japan Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 45. By Type, Japan Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 46. By Application, Japan Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 47. South Korea Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 48. By Company, South Korea Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 49. By Type, South Korea Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 50. By Application, South Korea Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 51. Southeast Asia Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 52. By Company, Southeast Asia Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 53. By Type, Southeast Asia Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 54. By Application, Southeast Asia Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 55. India Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 56. By Company, India Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 57. By Type, India Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 58. By Application, India Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 59. Middle East & Asia Drugs for Irritable Bowel Syndrome Revenue, 2019-2030, (US$ Million)

Figure 60. By Company, Middle East & Asia Drugs for Irritable Bowel Syndrome Market Share, 2019-2023

Figure 61. By Type, Middle East & Asia Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 62. By Application, Middle East & Asia Drugs for Irritable Bowel Syndrome Revenue Market Share, 2023 VS 2030

Figure 63. Research Methodology

Figure 64. Breakdown of Primary Interviews

Figure 65. Bottom-up Approaches

Figure 66. Top-down Approaches